In this study, we demonstrate that CD4+ T cells specific to the disease‐driving antigen in CeD can be isolated directly and in high numbers from the inflammatory lesion, by using FACS and a small set of phenotypic markers without the use of HLA tetramers. The gene discussed is CD4; the disease is cranioectodermal dysplasia.